A group of eight related reporting persons led by Raymond Debbane filed a Schedule 13G with the SEC on November 19, 2026, disclosing beneficial ownership positions in Rezolute, Inc. common stock as of November 13, 2026.
Key Highlights
- Raymond Debbane reported sole voting and dispositive power over 7,204,256 shares, representing 6.1% of Rezolute, Inc. common stock.
- Invus Public Equities, L.P. directly held 6,319,631 shares, equal to 5.3% of the class, according to the filing.
- Avicenna Life Sci Master Fund LP directly held 884,625 shares, representing 0.7% of the class.
- Eight reporting persons are named in the filing: Invus Public Equities, L.P.; Invus Public Equities Advisors, LLC; Invus Global Management, LLC; Siren, L.L.C.; Avicenna Life Sci Master Fund LP; Avicenna Life Sci Master GP LLC; Ulys, L.L.C.; and Raymond Debbane.
- The triggering event date for the filing is stated as November 13, 2026.
- Securities covered are shares of common stock, par value $0.001 per share, CUSIP 76200L309, issued by Rezolute, Inc.
Invus-Affiliated Entities and Debbane Report Rezolute Holdings as of November 13, 2026
According to the Schedule 13G filed November 19, 2026, Invus Public Equities, L.P., a Bermuda limited partnership, directly held 6,319,631 shares of Rezolute, Inc. common stock as of November 13, 2026. The filing states that Invus Public Equities Advisors, LLC serves as the general partner of Invus Public Equities and, as a result, may be deemed to beneficially own those same shares. Invus Global Management, LLC, in turn, is identified as the managing member of Invus Public Equities Advisors, and Siren, L.L.C. is identified as the managing member of Invus Global Management. Each of these entities reported sole voting power and sole dispositive power over 6,319,631 shares, with no shared voting or dispositive power, and each reported 5.3% of the class.
The filing separately reports that Avicenna Life Sci Master Fund LP, a Cayman Islands limited partnership, directly held 884,625 shares, also as of November 13, 2026. Avicenna Life Sci Master GP LLC and Ulys, L.L.C. each reported the same 884,625-share position, representing 0.7% of the class. Raymond Debbane, a Panama citizen, reported the largest individual aggregate beneficial ownership figure in the filing: 7,204,256 shares, representing 6.1% of the class, with sole voting and sole dispositive power and no shared power. All reporting persons list their principal address as 750 Lexington Avenue, 30th Floor, New York, NY 10022.
The filing covers Rezolute, Inc. common stock, par value $0.001 per share, CUSIP 76200L309. Rezolute, Inc.'s principal executive offices are listed as 275 Shoreline Drive, Suite 500, Redwood City, CA 94065. The filing does not specify a stock exchange or ticker symbol in the Schedule 13G text itself.
What Was Disclosed
Eight affiliated reporting persons filed a joint Schedule 13G disclosing beneficial ownership in Rezolute, Inc. common stock as of November 13, 2026. The largest aggregate position reported belongs to Raymond Debbane at 7,204,256 shares, or 6.1% of the class.




Please wait processing your request...